Neurosurgery Department, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Clin Neurol Neurosurg. 2024 Jul;242:108317. doi: 10.1016/j.clineuro.2024.108317. Epub 2024 May 6.
Symptomatic intracranial arachnoid cysts are treated mainly through surgical resection, endoscopic fenestration, or by implanting cystoperitoneal (CP) shunt. However, the use of a specific technique remains controversial. The purpose of this study is to discuss these surgical modalities in symptomatic patients with intracranial arachnoid cysts (ACs) and investigate which has better outcomes and less complications by comparing variable preoperative and postoperative parameters.
An analysis of thirty-nine symptomatic patients who underwent intracranial arachnoid cyst surgery in the department of neurosurgery between 2009 and 2023 was performed. Patients were retrospectively compared based on age group, gender, anatomical location, laterality, type of intervention, clinical and volumetric changes, postoperative complications and outcome.
Of the 39 patients, 20 patients (51.28 %) received CP shunt. Eleven patients (28.2 %) underwent endoscopic fenestration, and 8 patients (20.5 %) had surgical resection. The age at the time of first operation ranged from 1 month to 59.9 years (mean age: 16.8 years), and the pediatric patients were 25 (64.1 %). The most common initial symptom was headache which was observed in 19 patients (48.7 %), followed by seizure in 12 patients (30.8 %), vomiting in 11 patients (28.2 %), visual dysfunction in 8 patients (20.5 %), drowsiness in 8 patients (20.5 %), visual symptoms in 8 patients (20.5 %), cognitive impairment in 4 patients (10.3 %), focal neurological deficits in 3 patients (7.7 %), and cranial nerve involvement in 1 patient (2.6 %). 24 patients (61.5 %) showed improvement while in 15 patients (38.5 %) the symptoms persisted or worsened. Postoperatively, patients were followed up for an average of one year. The highest improvement rate was noted in endoscopic fenestration with 9 improved patients (81.8 %), followed by surgical resection with 5 symptom-free patients (62.5 %). The worst outcomes were seen in cystoperitoneal shunt with only half of the patients were relieved (50 %). Complications developed in 2 patients (25 %) who underwent surgical resection, 5 patients (45.5 %) who had endoscopic fenestration, and 13 patients (65 %) who had cystoperitoneal shunting.
Endoscopic fenestration has the highest improvement rate, the lowest serious complications along with being the least invasive technique. These features make it the optimal modality in treatment of ACs. Surgical resection or cystoperitoneal shunt can be considered as secondary techniques when patients report unchanged or worsening symptoms.
有症状的颅内蛛网膜囊肿主要通过手术切除、内镜下开窗或植入囊腔-腹腔(CP)分流来治疗。然而,具体技术的选择仍存在争议。本研究旨在讨论这些在有症状的颅内蛛网膜囊肿(AC)患者中的手术方式,并通过比较术前和术后的各种参数来探讨哪种方法的效果更好,并发症更少。
回顾性分析 2009 年至 2023 年在神经外科接受颅内蛛网膜囊肿手术的 39 例患者。根据年龄组、性别、解剖位置、侧别、干预类型、临床和体积变化、术后并发症和结果对患者进行回顾性比较。
39 例患者中,20 例(51.28%)接受 CP 分流。11 例(28.2%)患者接受内镜下开窗,8 例(20.5%)患者接受手术切除。首次手术时的年龄为 1 个月至 59.9 岁(平均年龄:16.8 岁),儿科患者为 25 例(64.1%)。最常见的首发症状是头痛,有 19 例(48.7%)患者出现头痛,其次是癫痫发作 12 例(30.8%)、呕吐 11 例(28.2%)、视力障碍 8 例(20.5%)、嗜睡 8 例(20.5%)、视力症状 8 例(20.5%)、认知障碍 4 例(10.3%)、局灶性神经功能缺损 3 例(7.7%)和颅神经受累 1 例(2.6%)。24 例(61.5%)患者症状改善,15 例(38.5%)患者症状持续或加重。术后患者平均随访 1 年。内镜下开窗的改善率最高,9 例(81.8%)患者改善,其次是手术切除,5 例(62.5%)患者无症状。CP 分流的结果最差,只有一半患者(50%)得到缓解。2 例(25%)接受手术切除的患者、5 例(45.5%)接受内镜下开窗的患者和 13 例(65%)接受 CP 分流的患者出现并发症。
内镜下开窗的改善率最高,严重并发症发生率最低,同时创伤最小,是治疗 AC 的最佳方法。当患者报告症状无变化或加重时,手术切除或 CP 分流可作为二线治疗方法。